Lanzamiento Enero 2027

Ensayo controlado aleatorizado2013Financiación no declarada

Effect of high doses of vitamin D on arterial properties, adiponectin, leptin and glucose homeostasis in type 2 diabetic patients

Breslavsky A, Frand J, Matas Z, Boaz M, Barnea Z, Shargorodsky M

Clinical nutrition (Edinburgh, Scotland) · 104 citas

Etiquetas de revisión

Financiación no declarada

Datos neutrales que nuestra revisión registró sobre cómo se hizo este estudio. Describen el método, nunca si nos gusta el resultado.

Cómo se estudió

Diseño
Ensayo controlado aleatorizado (indexado por PubMed)
Estudiado en
Personas
Resultado principal
Marcadores de salud y funcionamiento

Quién lo pagó

Financiación
Financiación no declarada

Publicación

Publicado
2013-02-27 · Clin Nutr · vol. 32 · número 6 · págs. 970–975
Editorial
Elsevier BV
Citado
148 citas · más que el 99% de estudios similares · 10.9× el promedio de su campo
Impacto
Entre el 10 % más citado de su campo
Referencias
33 trabajos
Acceso
De pago
Áreas de investigación
Vitamin D Research Studies · Adipokines, Inflammation, and Metabolic Diseases · Diabetes, Cardiovascular Risks, and Lipoproteins
Palabras clave
vitamin D supplementation, type 2 diabetes, augmentation index, glucose homeostasis, adiponectin, leptin, insulin resistance, cardiovascular risk, 25-hydroxyvitamin D, leptin/adiponectin ratio
MeSH
arteries, humans, diabetes mellitus, type 2, insulin resistance, insulin, leptin, blood glucose, vitamin d, hypoglycemic agents, body mass index, administration, oral, linear models, double-blind method, homeostasis, dose-response relationship, drug, dietary supplements, aged, middle aged, female, male, adiponectin

6 autores

  • Anna Breslavsky🇮🇱Wolfson Medical Center
  • Jacob Frand🇮🇱Wolfson Medical Center
  • Zipora Matas🇮🇱Wolfson Medical Center
  • Mona Boaz🇮🇱Tel Aviv University; Wolfson Medical Center
  • Zvi Barnea🇮🇱Wolfson Medical Center
  • Marina Shargorodsky🇮🇱 · autor de correspondenciaTel Aviv University; Wolfson Medical Center

Resumen

El texto original del estudio, en el idioma en que se publicó.

Background & aims

Vitamin D supplementation has the potential to alleviate the cardiovascular damage in diabetic patients. The present study was designed to evaluate long term impact of high doses of vitamin D on arterial properties, glucose homeostasis, adiponectin and leptin in patients with type 2 diabetes mellitus.

Methods and results

In randomized, placebo-controlled study 47 diabetic patients were assigned into two groups: Group 1 received oral daily supplementation with vitamin D at a dose of 1000 U/day for 12 months. Group 2 received matching placebo capsules. Blood sampling for metabolic parameters, including fasting glucose, lipid profile, HbA1C, insulin, hs-CRP, 25 OH Vit D, adiponectin and leptin was performed at baseline and at the end of the study. Insulin resistance was assessed by homeostasis model assessment (HOMA-IR). Central aortic augmentation index (AI) was evaluated using SphygmoCor.

Results

The two groups were similar at baseline in terms of hemodynamic parameters. After 12 months, AI decreased significantly during the treatment period in patients received vitamin D (p < 0.0001) and did not change in placebo group. Glucose homeostasis parameters, leptin as well as leptin adiponectin ratio did not change in both groups. 25 OH Vit D level significantly increased (p = 0.022) and circulating adiponectin marginally increased (p = 0.065) during 12 month treatment period in active treatment and did not change in placebo group.

Conclusions

High doses of vitamin D supplementation in diabetic patients was associated with significant decrease in AI during one year treatment. This beneficial vascular effect was not associated with improvement in glucose homeostasis parameters.

Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial.

Confianza de la comunidad

Cargando…

¿Cuánto confías en los hallazgos de este estudio?

0 · nada10 · totalmente

Comentarios

¿Algo está mal aquí?

Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.

Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.